Tricuspid insufficiency after cardiac-implantable electronic device placement

References

• Najib MQ, Vittala SS, Challa S, et al. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads. Tex Heart Inst J. 2013;40(5):529–533.
   Web of Science ®Google Scholar
• Pokorney SD, Parzynski CS, Daubert JP, et al. Temporal trends in and factors associated with use of single- versus dual-coil implantable cardioverter-defibrillator leads: data from the NCDR ICD registry. JACC Clin Electrophysiol. 2017;3(6):612–619.
   Google Scholar
• Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads. Am J Cardiol. 2016;117(6):988–992.
   PubMed Web of Science ®Google Scholar
• Carlson MD. ICD leads and postmarketing surveillance. N Engl J Med. 2012;366(10):967.
   Web of Science ®Google Scholar
• Pappalardo OA, Votta E, Selmi M, et al. 4D MDCT in the assessment of the tricuspid valve and its spatial relationship with the right coronary artery: a customized tool based on computed tomography for the planning of percutaneous procedures. J Cardiovasc Comput Tomogr. 2020;14(6):520–523.
   Web of Science ®Google Scholar
• Goud A, Abdelqader A, Dahagam C, et al. Isolated pulmonic valve endocarditis presenting as neck pain. J Community Hosp Intern Med Perspect. 2015;5(6):29647.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim TH, Kim WS. Permanent pacemaker lead induced severe tricuspid regurgitation in patient undergoing multiple valve surgery. Korean J Thorac Cardiovasc Surg. 2015;48:129–133.
   Google Scholar
• Saran N, Said SM, Schaff HV, et al. Outcome of tricuspid valve surgery in the presence of permanent pacemaker. J Thorac Cardiovasc Surg. 2018;155(4):1498–1508.e3.
   Web of Science ®Google Scholar
• Dahou A, Magne J, Clavel MA, et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis). JACC Cardiovasc Interv. 2015;8(4):588–596.
   Web of Science ®Google Scholar
• Hayashi T, Ono H, Kaneko Y. Echocardiographic assessment of ventricular contraction and synchrony in children with isolated complete atrioventricular block and epicardial pacing: implications of interventricular mechanical delay. Echocardiography. 2018;35:1370–1377.
   Web of Science ®Google Scholar
• Thibault B, Ritter P, Bode K, et al. Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study. Heart Rhythm. 2019;16(7):1047–1056.
   Web of Science ®Google Scholar
• Mazzone P, Melillo F, Radinovic A, et al. Use of the new rotating dilator sheath TightRail™ for lead extraction: a bicentric experience. J Arrhythm. 2020;36(2):343–350.
   Web of Science ®Google Scholar
• Eleid MF. A step forward for transcatheter tricuspid valve repair. JACC Cardiovasc Interv. 2017;10(19):2004–2005.
   Web of Science ®Google Scholar
• Khattak F, Gupta A, Alluri K, et al. Rate and predictors of electrical failure in non-recalled defibrillator leads. Indian Pacing Electrophysiol J. 2019;19:100–103.
   Google Scholar
• Fanari Z, Hammami S, Hammami MB, et al. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol. 2015;48:791‐797.
   Web of Science ®Google Scholar
• He H, Li X, Ke B, et al. Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation. J Interv Card Electrophysiol. 2019;55:213‐24.
   Web of Science ®Google Scholar
• Lee RC, Friedman SE, Kono AT, et al. Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors. Pacing Clin Electrophysiol. 2015;38:1267‐1274.
   Web of Science ®Google Scholar
• Bohbot Y, Chadha G, Delabre J, et al. Characteristics and prognosis of patients with significant tricuspid regurgitation. Arch Cardiovasc Dis. 2019;112:604‐614.
   Web of Science ®Google Scholar
• Bansal R, Parakh N, Gupta A, et al. Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J Interv Card Electrophysiol. 2019;56(1):63–70.
   PubMed Web of Science ®Google Scholar
• Van De Heyning CM, Elbarasi E, Masiero S, et al. Prospective study of tricuspid regurgitation associated with permanent leads after cardiac rhythm device implantation. Can J Cardiol. 2019;35(4):389–395.
   Web of Science ®Google Scholar
• Sulke N, Chambers J, Dritsas A, et al. A randomized double-blind crossover comparison of four rate-responsive pacing modes. J Am Coll Cardiol. 1991;17:696‐706.
   Web of Science ®Google Scholar
• Al-Bawardy R, Krishnaswamy A, Rajeswaran J, et al. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol. 2015;38(2):259–266.
   Web of Science ®Google Scholar
• Mediratta A, Addetia K, Yamat M, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7(4):337–347.
   Web of Science ®Google Scholar
• Addetia K, Harb SC, Hahn RT, et al. Cardiac implantable electronic device lead-induced tricuspid regurgitation. JACC Cardiovasc Imaging. 2019;12(4):622–636.
   Web of Science ®Google Scholar
• Polewczyk A, Kutarski A, Tomaszewski A, et al. Lead dependent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction. Cardiol J. 2013;20(4):402–410.
   Web of Science ®Google Scholar
• Reddy VY, Knops RE, Sperzel J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129(14):1466–1471.
   PubMed Web of Science ®Google Scholar